Gynecologists support the project currently under study to extend to boys the recommendation for the human papillomavirus (HPV) vaccine, a virus responsible for cervical cancer, its national representative body, the FNCGM, told AFP.
"Universal vaccination (girls and boys 11 to 14 years old, up to 19 years old) would reduce the number of cancers due to HPV in greater population coverage," Dr. Pia de Reilhac's president said in a statement. to AFP.
Vaccination reimbursed in young girls
In France, vaccination is now recommended and reimbursed for all girls aged 11 to 14 and between 15 and 19 years in case of recovery. It is also recommended up to 26 years of age in men who have sex with men (MSM) and in immunocompromised patients.
According to a draft opinion issued October 30, the High Health Authority (HAS) is considering extending this recommendation to young boys, "to curb transmission" of HPV. The health authority had been seized on this matter by the Ministry of Health.
"Medical gynecologists, by the (voice of) the National Federation of Colleges of Medical Gynecology (FNCGM), gave a very favorable opinion to this recommendation," said the FNCGM, according to which it is subject to "public consultation & # 39; November & # 39 ;.
Sexually transmitted HPV-related infections can cause cancer years in women and men, the cervix, vagina, penis, anus, or throat.
About 1,750 new cases of HPV-related cancer occur each year in France in men and 4,580 in women. The only cervical cancer still kills 1,100 women every year in France and 900 new cases are diagnosed.
Some countries, such as the United States, already recommend that all preteens be vaccinated against HPV at 11 or 12 years of age before being exposed to this viral risk.